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Abstract 
 
Syrbactins are cyclic peptide derivatives which are known to inhibit the eukaryotic proteasome by 
irreversible covalent binding to its catalytic sites. The only two members of this family characterized 
to date, syringolin A and glidobactin A, are secreted by certain strains of Pseudomonas syringae pv. 
syringae and strain K481-B101 from the order Burkholderiales, respectively. Syrbactins are the 
products of mixed non-ribosomal peptide/polyketide synthases encoded by gene clusters with a 
characteristic architecture. Similar, but not identical gene clusters are present in several other 
bacterial genomes, including that of Photorhabdus luminescens subsp. laumondii TT01, which is 
therefore hypothesized to be able to produce a syrbactin-type proteasome inhibitor. Here we report 
the cloning of the putative syrbactins synthetase encoding gene cluster of Ph. luminescens into a 
cosmid vector and its heterologous expression in Pseudomonas putida. Analysis of culture 
supernatants of transformed Ps. putida by HPLC and mass spectrometry revealed the presence of 
glidobactin A, indicating that the syrbactins-like gene cluster of Ph. luminescens encodes a 
glidobactin A synthetase and that this organism has the capacity to synthesize glidobactin A. 
 
 
Introduction 
 
Syrbactins are a structural class of potent proteasome inhibitors that covalently and irreversibly bind 
to the active site threonine residues of catalytic proteasome subunits (Groll et al., 2008; Krahn et al., 
2011). Syringolin A (Figure 1), one of the two well characterized syrbactins to date, is secreted by 
strains of the phytopathogenic bacterium Ps. syringae  pv.  syringae (Wäspi et al., 1998). It is the 
major variant of a small family of closely related compounds thought to be the products of the same 
3 
 
 
 
synthetase (Wäspi et al., 1999), which is a mixed non-ribosomal peptide synthetase/polyketide 
synthetase (NRPS/PKS) encoded by the sylA-sylE gene cluster (Amrein et al., 2004). Analysis of the 
gene cluster, in particular of the architecture of the sylC and sylD genes, have allowed to postulate a 
biosynthesis model which completely explains the tripeptide part containing the ring structure 
(Amrein et al., 2004). Recently, other experiments also shed light on the biosynthesis of the tail part 
of syringolin A, including its unusual ureido group (Imker et al., 2009; Ramel et al., 2009; Wuest et 
al., 2011). Glidobactin A, the other well characterized syrbactin member, has a twelve-membered 
ringstructure similar to the one of syringolin A, but exhibits an acylated tail (Figure 1A). It is 
secreted by an unknown species belonging to the order Burkholderiales and is the product of a 
synthetase encoded by the glbA-glbH gene cluster, which is homologous to the syringolin gene 
cluster (Figure 1B) (Schellenberg et al., 2007). Like in the case of syringolin A, the architecture of 
the sylC and sylD homologs glbF and glbC, suggested a glidobactin A biosynthesis model which 
completely explains the twelve-membered ring structure with the exception of the hydroxyl group 
(Schellenberg et al., 2007). Recently, the acylation of the N-terminal threonine residue has been 
shown to be mediated by the glbFgene product, which, in addition to activating the threonine 
residue, also mediates its acylation using acyl-CoA as a donor (Imker et al., 2010). Glidobactin A is 
the major variant of a family of compounds also named cepafungins that differ mostly in the 
structure of the fatty acid tail (Oka et al., 1988a; Oka et al., 1988b; Terui et al., 1990). 
Among the bacteria whose genomes have been completely sequenced, sequence comparison 
revealed gene clusters similar to glbA-glbH in the insect pathogen Photorhabdus luminescens as 
well as in the human pathogens Photorhabdus asymbiotica, Burkholderia pseudomallei (causing 
agent of melioidosis), and B. oklahomensis, while B. mallei strains contain a disrupted cluster 
(Schellenberg et al., 2007). In comparison to the glb gene cluster, these organisms lack glbA and 
glbH homologues, and in some cases also a glbE and a glbG homologue (Figure 1B). While glbA 
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encodes a LysR-type transcription factor and glbE an MbtH-like peptide, both of which are 
irrelevant for structural considerations (Lautru et al., 2007; Rackham et al., 2010; Schellenberg et 
al., 2007; Zhang et al., 2010), the functions of glbG and glbH are hitherto unknown. 
We were interested to compare the structure of the Ph. luminescens syrbactins-like gene 
cluster, which encompasses genes plu1881-1877, and the structure of the product of the synthetase 
encoded by these genes in order to improve our ability to derive product structure from the genes 
and their architecture. Plu1881-1877are homologous to glbB-glbG, except that the MbtH-like 
protein encoded by glbE is missing (Figure 1B). However, all our efforts to isolate putative 
syrbactins from Ph. luminescens spp. laumondii (Pll) TT01 grown under a variety of conditions 
failed. Thus, we decided to clone plu1881-1877 and express the gene cluster in a heterologous 
system. Here we show that Ps. putida harboring a cosmid-borne plu1881-1877 gene cluster secretes 
bona fide glidobactin A, suggesting the Pll is capable to synthesize this potent proteasome inhibitor. 
 
 
Materials and methods 
 
Bacterial strains and culture conditions 
Unless stated otherwise, Escherichia coli strains, Ps. putida P3 (Senior et al., 1976), and Ph. 
luminescens spp. laumondii TT01 (accession no. DSM 15139, German Collection of Microorganisms and 
Cell Cultures (DSMZ,)) were grown in LB medium on a shaker at 220 rpm at 37° C, 28° C, or 30 ° C, 
respectively.  
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Cloning of the plu1881-1877 gene cluster and transfer to P. putida P3 
If not stated otherwise, standard procedures were used (Ausubel et al., 1987). Genomic DNA of P. 
luminescence subsp. laumondii TT01 was isolated using Genomic tip-100/G columns (Qiagen, 
Hilden, Germany) according to instructions of the manufacturer. Ten µg of genomic DNA was 
digested with the locally unique restriction enzymes SalI and XbaI (positions 2242496 and 2216847, 
respectively; accession no. NC_005126), separated on a 0.5% agarose gel at 4° C, blotted onto a 
nylon membrane, and hybridized to a 32P-labeled probe amplified from plu1880 with primers 
plu1880_f and plu1880_r (Table 2) in order to verify the expected fragment size. DNA fragments 
larger than 20 kp were cut out of an identical gel, purified as described (Ramel et al., 2009), and 
cloned into HindIII/BamHI digested broad-host range cosmid pLAFR3 (Staskawicz et al., 1987) 
with the help of adapters obtained by annealing oligonucleotides Hind-Sal_Adapt_H/ Hind-Sal-
Adapt-S and Xba-Bam-Adapt-X/Xba-Bam-Adapt-B, respectively (Table 2). After the adapters were 
ligated to the digested vector at 4° C overnight, the modified vector was separated from 
oligonucleotides by agarose gel electrophoresis and purified using Wizard® SV Gel and PCR Clean-
Up System (Promega, Madison, WI, USA). Isolated genomic DNA fragments (>20 kb) were then 
ligated with the modified vector for two days at 4o C. The products were concentrated by ethanol 
precipitation and packaged into λ-phage particles using Gigapack III Plus Packaging Extract 
(Agilent Technologies, Basel, Switzerland). The library was plated on E. coli XL-1 Blue MRA 
(Stratagene, La Jolla, California) and screened according to instructions of the manufacturer using 
the 32P-labeled plu1880 probe described above. Positive clones were isolated and completeness of 
the plu1881-1877 gene cluster was verified by PCR using primers amplifying the left and right end 
of the cluster (primers plu1881_f/ plu1881_r and plu1877_f/plu1877_r, respectively; Table 2). The 
recombinant cosmid was named pL3plu and transferred from E. coli XL-1 Blue MRA to  
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Ps. putida P3 by triparental mating using the E. coli helper strain HB101 (pRK600) (Christensen et 
al., 1999). 
 
Preparation and analysis of methanolic extracts 
Five mL SRMAF medium (Mo and Gross, 1991) containing 10 µg/mL tetracycline were inoculated 
with Ps. putida and shaken at 220 rpm over night at 28° C. The culture was used to inoculate 100 mL 
SRMAF medium. These cultures were grown at 28o C either for 2 days at 220 rpm (shaken cultures), 
or without agitation for 5 days (still cultures). After centrifugation at 10 000 x g for 10 min, pelleted 
cells were resuspended in 90% HPLC-grade methanol and shaken at 250 rpm for 2 hours at room 
temperature. After centrifugation at 10 000 x g for 15 min, supernatants were filtered through 0.22 
μm Steritop filters (Millipore, Molsheim, France) and stored at +4oC until used. 
HPLC analysis was performed as described previously (Titus and Roundy, 1990) with some 
modifications.  Extracts were concentrated 10-fold by complete evaporation and dissolution in 50% 
methanol followed by filtration through Millex GP filter units (0.22 μm pore size; Millipore, 
Molsheim, France).  Twenty μL of filtrate was injected into a 250 mm x 4.6 mm Hypersil ODS 5 
μm column (Dr. Maisch GmbH, Ammerbuch, Germany) which was connected to UltiMate 3000 
HPLC system (Thermo Fisher, Olten, Switzerland). Equilibration of the column and isocratic 
separation of components was performed with a methanol:water (3:1) solution at a flow rate of 1 
mL/min. 
Methanolic extracts (50% methanol) were diluted 10:1 or 100:1 with CH3CN and analyzed 
with a Waters Acquity UPLC system (Waters, Milford, USA) connected to a Bruker maXis QTof 
high-resolution mass spectrometer (Bruker Daltonics, Bremen, Germany). An Acquity BEH C18 
HPLC column (1.7 µm, 2.1x100 mm fitted with a 2x2 mm guard column) has been used with a 
mixture of H2O + 0.1% HCOOH (A) and CH3CN + 0.1% HCOOH (B) solvent (0.3 ml flow rate, 
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linear gradient from 70 to 100% B within 3 min followed by flushing with 100% B for 1 min). The 
mass spectrometer was operated in the positive electrospray ionization mode at 4,000 V capillary 
voltage, -500 V endplate offset, with a N2 nebulizer pressure of 1.6 bar and dry gas flow of 8 l min-1 
at 200°C. MS acquisitions were performed in the mass range from m/z 50 to 1,200 at 20,000 
resolution (full width at half maximum) and 1.5 scan s-1. Masses were calibrated below 2 ppm 
accuracy with a 2 mM solution of sodium formate over m/z 158 up to 1450 mass range prior to 
analysis. The presence of Glidobactin was confirmed by calculation of extracted ion chromatograms 
of the [M + H]+ signal at m/z 521.3333±0.05. 
 
 
Results 
 
In order to identify compounds produced by the plu1881-1877-encoded enzymes, a heterologous 
expression system was explored using Ps. putida strain P3, which has been successfully employed 
previously for the expression of the syringolin synthase cluster (syl) (Ramel et al., 2009). Analysis 
of the Pll TT01 genomic region containing plu1881-1877 revealed unique SalI and Xba I restriction 
sites, with the SalI site being 2.54 kb upstream of plu1881 and the XbaI located 4.77 kb downstream 
of plu1877. These restriction sites, which delimit a 25.65 kb fragment, completely contain plu1881-
1877. The presence and uniqueness of these sites was confirmed by DNA gel blot analysis of 
SalI/XbaI-digested genomic DNA of Pll TT01 using a plu1880-derived hybridization probe (data 
not shown). A sub-genomic library was then prepared from SalI/XbaI-digested genomic DNA which 
was size-fractionated by separation on an agarose gel. Fragments larger than 20 kb were eluted and 
cloned into the broad-host range cosmid vector pLAFR3, packaged into λ-phage particles, and 
transfected into E. coli. The library was screened by hybridization with a plu1880-derived probe. 
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Positive colonies were isolated and presence of the entire cluster was the verified by PCR using 
primers amplifying the 5’-end of plu1881 and 3’-end  of plu1877.  The recombinant cosmids of 
positive clones were transferred into Ps. putida P3. Presence of the cluster in transconjugant 
candidates was verified by PCR using plu1881, plu1880 and plu1877-derived primers. Metabolite 
production was then tested by growing bacteria in a minimal medium either under constant shaking 
for two days, or as still cultures for five days. Methanolic extracts of pelleted cells were prepared 
and analyzed by HPLC.  Comparison of HPLC profiles from transformed bacteria carrying the 
plu1881-1877 gene cluster with profiles from the untransformed control strain reproducibly revealed 
a differential peak when cultures were grown under still culture conditions. As shown in the Figure 
2, conditioned media of the transformed P. putida strain revealed a peak with a retention time 
identical to the one of isolated glidobactin A (8.7 min). LC-HR-ESI-MS of extracts revealed a quasi-
molecular ion with an m/z of 521.33327, corresponding to a formula of C27H45N4O6 (hydrogen 
adduct, m/z 521.33336, SD of 0.18 ppm), which is identical to the one of the hydrogen adduct of 
glidobactin A (Figure 3). Thus, we conclude that the product of the NRPS/PKS encoded by the 
plu1881-1877 gene cluster of Pll TT01 heterologously expressed in Ps. putida is glidobactin A, and 
that Pll TT01 is capable to produce this potent proteasome inhibitor. 
 
 
Discussion 
 
We were hitherto unable to detect glidobactin A or similar compounds in Pll cultures grown in 
various media and conditions either by HPLC or by proteasome inhibition assays (unpublished 
results). Conditions explored included still and shaken cultures in minimal and insect culture media 
supplemented with insect hemolymph or proline, ingredients which have been shown to activate 
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expression of virulence-associated genes in Pll TT01 (Crawford et al., 2010). While these 
compounds were indeed able to slightly induce expression of the cluster, the level of production was 
apparently still below detection limits (data not shown). It is a notorious problem that for many 
NRPS and PKS gene clusters identified by genome sequencing, the products synthesized by the 
encoded enzymes remain unknown because these genes are not expressed under the culture 
conditions used or explored. In contrast to the glidobactin A gene cluster of K481-B101, the Pll 
syrbactin gene cluster does not encompass a transcriptional activator gene, suggesting that a 
regulator encoded elsewhere in the genome is involved. As to why the Pll gene cluster is active in P. 
putida, we can only speculate. One possibility is that the Pll gene cluster is activated in this 
organism by a regulator active under the culture conditions employed. Pll may also harbor a 
repressor of the syrbactin gene cluster that is absent in P. putida. In addition, the fact that multiple 
copies of the cosmid carrying the Pll gene cluster likely are present may also play a role. 
 Comparison of the amino acid residues forming the binding pocket of the NRPS modules 
encoded by plu1880 and plu1878 with the ones of their homologues of the glidobactin A producing 
strain K481-B101 suggests that the former activate the same amino acids as the modules present in 
GlbC and GlbF, respectively (Table 1). However, the detection of bona fide glidobactin A in culture 
supernatants of P. putida carrying the plu1881-1877 gene cluster was unexpected because the gene 
cluster lacks a glbH homologue. The product of this gene is hypothesized to play a role in features 
of glidobactin A left unexplained by the biosynthesis model (Imker et al., 2010; Schellenberg et al., 
2007), i.e. in the hydroxylation of the lysine residue, or in the modifications exhibited by the minor 
variants, which are all in the fatty acid tail with the exception of glidobactin G, where a 
hydroxymethyl group replaces the methyl group attached to the ring structure (Oka et al., 1988a; 
Oka et al., 1988b; Terui et al., 1990). Because glbH was not needed for glidobactin A biosynthesis 
in Ps. putida carrying plu1881-1877, glbH would seem to play a role in a modification leading to a 
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minor variant not present in Pll, and not in the hydroxylation of the lysine residue. Of course, it 
cannot be completely excluded that a gene in the Ps. putida genome substitutes for a glbH 
homologue, although BLAST analyses of the completely sequenced Ps. putida (and Pll) strains 
revealed no close homologue. 
The plu1881-1877 gene cluster also lacks a glbE homologue, which encodes an MbtH-like 
peptide. However, it has been shown that MbtH proteins encoded by different NRPS clusters are 
able to substitute for each other (Felnagle et al., 2010; Zhang et al., 2010), and BLAST analysis 
reveals that both Pll and Ps. putida contain at least one MbtH-encoding gene in other NRPS gene 
clusters which may provide the function if needed.  
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Figure legends 
 
Figure 1 
(A) Structural formula of glidobactin A. The compound is a tripeptide derivative with a 12-
membered macrolactam ring and a fatty acid tail attached to the N-terminal threonine. (B) 
Alignment of the glidobactin synthetase gene cluster from K481-B101 (glbA-H) with the 
homologous gene cluster in Ph. luminescens ssp. laumondii TT01 (plu1881-1877). Vectored boxes 
indicate open reading frames (ORF’s). Homologous genes are colored in black, whereas those that 
are absent in Pll TT01 are given in grey. 
 
Figure 2 
HPLC profiles of wild-type Ps. putida extract (A), extract from Ps. putida expressing the plu1881-
1877 gene cluster (B), and isolated glidobactin A standard (C). 
 
Figure 3 
(A) Total ion UPLC chromatogram of methanolic extract of Ps. putida carrying the plu1881-1877 
gene cluster. (B) Magnified peak with retention time (RT) of 1.55 minutes that is expected to 
contain glidobactin. (C) UPLC-MS spectrum at RT 1.55 min. The two signals marked with asterisks 
correspond to protonated glidobactin (C27H45N4O, m/zexp 521.33327, m/zcalc.  521.33336, 0.18 ppm 
error) and a glidobactin fragment generated in the ion source (C11H20N3O3, m/zcalc 242.14992, m/zexp 
242.14986, 0.24 ppm). The latter corresponds to the macrolactam ring of glidobactin without the 
extracyclic threonine and fatty acid tail. 
Table 1. Prediction of amino acid specificity of NRPS modules encoded by glbC/glbF and 
plu1880/plu1878 
  Positiona     
Module 235 236 239 278 299 301 322 330 331 517 Observed Predictedb 
GlbF D F W N I G M V H K Thr Thr 
Plu1878 D F W N I G M V H K Thr Thr 
             GlbC-1 D L G D V G S I D K Lys Lys 
Plu1880-1 D L G D V G S I D K Lys Lys 
             GlbC-2 D V G W I A G I V K Ala - 
Plu1880-2 D V G W I T G I V K Ala - 
 
a Position of amino acid residues (given one-letter code) in the binding pocket of each of the NRPS 
modules as analyzed by NRPS-PKS software at http://www.nii.res.in/nrps-pks.html (Ansari et al., 
2004). 
b Amino acids (given in three-letter code) predicted to be activated by the respective NRPS module 
using the NRPSsp webtool at http://www.nrpssp.com (Prieto et al., 2012). 
Table 2.  List of oligonucleotides used 
Name Sequence Overhang 
Hind-Sal-Adapt-H 5'-AGCTTGGAAAGCTT HindIII 
Hind-Sal-Adapt-S 5'-TCGACAAGCTTTCCA SalI 
Xba-Bam-Adapt-X 5'-CTAGACATGTCAGGAG XbaI 
Xba-Bam-Adapt-B 5'-GATCCTCCTGACATGT BamHI 
plu1881_ f 5'-TATGCGTTGTACCACCTTCG - 
plu1881_r 5'-GCCGTTAGATCGATTTGGTG - 
plu1880_f 5'-ATAAACTCCAGTGCGCCATC - 
plu1880_r 5'-ATGTGGATTGTCCCTTCTGC - 
plu1877_f 5'-TTCAAATTTAAAGTAATCGCTGAGG - 
plu1877_r 5'-CGCAGAACTTCTTAGCTCAATG - 
 



